Filing Details
Praxis Precision Medicines, Inc. (NASDAQ:PRAX) filed its quarterly report (Form 10-Q) with the Securities and Exchange Commission on August 06, 2026.
The Healthcare company reported Q0 revenue of .
10q filedNASDAQ:PRAX
Praxis Precision Medicines, Inc. (PRAX) Files Quarterly Report for Q0
Filing Details Praxis Precision Medicines, Inc. (NASDAQ:PRAX) filed its quarterly report (Form 10-Q) with the Securities and Exchange Commission on August 06, 2026. The Healthcare…
Market Context
Praxis Precision Medicines, Inc.'s stock currently trades at $370.16 with a market capitalization of $5.7B.
The 10-Q provides Praxis Precision Medicines, Inc.'s quarterly financial update, including unaudited financial statements and management commentary on recent performance. While less detailed than the annual 10-K, the 10-Q often contains timely information about emerging trends, updated risk factors, and changes in business conditions since the last filing.
All SEC filings for Praxis Precision Medicines, Inc. are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View PRAX Stock Page
Frequently Asked Questions
Where can I read PRAX's SEC filings?
Browse all filings on our PRAX SEC filings page.
What types of SEC filings does Praxis Precision Medicines, Inc. file?
Public companies like Praxis Precision Medicines, Inc. file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.